DocGo, Spect partner to improve in-home diabetic eye exams, screening services
Click Here to Manage Email Alerts
DocGo and Spect have partnered to provide mobile health clinicians a more cost-effective way to screen patients at home for diabetic retinopathy and other eye diseases, according to a DocGo press release.
“Annual diabetic eye exams are extremely important for people living with diabetes to ensure necessary treatment is received to protect their vision,” James Powell, MD, CEO of DocGo’s clinical practice group, said in the release. “Unfortunately, this exam is often skipped or delayed. It’s also one of the hardest HEDIS quality measures for health plans to close. By integrating Spect’s scalable and portable technology into DocGo’s technology and services, we can increase the number of eligible members screened and help improve patient care and health plan quality ratings.”
According to the release, DocGo selected Spect’s handheld retinal camera for its ease of use, ability to seamlessly integrate into clinical workflows, minimal training curve and availability of a remote Spect specialist to help facilitate the exam.
In addition, the partnership supports DocGo’s existing collaboration with health plans that contract with DocGo to help bridge gaps in screening by providing in-home medical visits, which will now benefit from the expanded use of Spect devices.
“Our focus is to maximize the results of each patient interaction we have,” Powell said in the release. “By integrating this technology, we can offer in-home diabetic eye exams as part of our comprehensive annual wellness visit or together with other screenings personalized for that patient.”
Read more about
Click Here to Manage Email Alerts